WWM
NVO

Wolff Wiese Magana’s Novo Nordisk NVO Stock Holding History

Wolff Wiese Magana’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-104
Closed -$7.18K – 1020
2025
Q2 		$7.18K Hold
104
– – ﹤0.01% 485
2025
Q1 		$7.22K Sell
104
-2,950
-97% -$244K ﹤0.01% 471
2024
Q4 		$263K Buy
3,054
+3,042
+25,350% +$329K 0.17% 89
2024
Q3 		$1.43K Buy
+12
New +$1.6K ﹤0.01% 797

Other funds holding NVO

Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Wolff Wiese Magana's NVO Position: Q3 2025 in Review

Wolff Wiese Magana sold out of Novo Nordisk (NVO) in Q3 2025, closing a stake of 104 shares — an estimated $7.18K sold.

Wolff Wiese Magana first reported a position in NVO in Q3 2024 and held it in 4 quarters. The position peaked at $263K in Q4 2024. 1,395 funds tracked by Wall St. Rank hold NVO as of Q3 2025.

  • Wolff Wiese Magana reported no remaining Novo Nordisk position as of Q3 2025 after selling out during the quarter.
  • Wolff Wiese Magana sold 104 Novo Nordisk shares in Q3 2025, an estimated $7.18K.
  • Wolff Wiese Magana first reported a position in Novo Nordisk in Q3 2024 and held it in 4 quarters.
  • Wolff Wiese Magana's Novo Nordisk position peaked at $263K in Q4 2024.
  • 1,395 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2025.

Based on Wolff Wiese Magana's 13F filing for Q3 2025, filed 28 Oct 2025.